Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism

Therapeutic Apheresis and Dialysis

Volumn 12, Issue SUPPL. 1, 2008, Pages

  Yajima, Aiji ^a   Akizawa, Tadao ^b   Tsukamoto, Yusuke ^c   Kurihara, Satoshi ^d   Ito, Akemi ^e  

^a Towa Hospital   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c Syuwa General Hospital   (Japan)

^d Saitama Tsukinomori Clinic   (Japan)

^e Ito Bone Histomorphometry Institute   (Japan)

Author keywords

Bone formation; Bone resorption; Cinacalcet hydrochloride; Secondary hyperparathyroidism; Vitamin D

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; VITAMIN D;

ADULT; AGED; BONE DISEASE; BONE METABOLISM; BONE MINERALIZATION; BONE TISSUE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CASE REPORT; CELL SURFACE; CONFERENCE PAPER; DRUG WITHDRAWAL; FIBROSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HISTOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; LOW DRUG DOSE; MORPHOMETRICS; OSTEOBLAST; OSTEOID; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT; TREATMENT DURATION;

AGED; BONE AND BONES; CALCIUM; DRUG THERAPY, COMBINATION; FIBROSIS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NAPHTHALENES; OSTEOBLASTS; PARATHYROID HORMONE; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; TIME FACTORS; VITAMIN D;

EID: 54949112851     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00630.x     Document Type: Conference Paper

References (25)

1. Martin KJ, Jûppner H, Sherrard DJ et al. First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int 2005 68 : 1236 43.
2. Cunningham J, Danese M, Olson K, Klassen P, Chertow GM. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 2005 68 : 1793 800.
3. Moe SM, Cunningham J, Bommer J et al. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 2005 20 : 2186 93.
4. Goodman WG, Goldin J, Kuizon BD et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000 342 : 1478 83.
5. National Kidney Foundation. K/DOQI clinical practice guideline for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003 42 : s1 s201.
6. Tsukamoto Y, Hanaoka M, Matsuo T, Saruta T, Nomura M, Takahashi Y. Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism. Am J Kidney Dis 2000 35 : 458 64.
7. Levine BS, Song M. Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. J Am Soc Nephrol 1996 7 : 488 96.
8. Malluche HH, Monier-Faugere MC, Wang G et al. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol 2008 69 : 269 77.
9. Quarles LD, Spiegel DM, Curzi M et al. The effects of one-year treatment with the calcimimetic AMG 073 (CINACALCET HCL) on bone health in ESRD patients with secondary hyperparathyroidism. J Am Soc Nephrol 2002 13 : 572A.
10. Moe SM, Coburn JW, Quarles LD et al. Achievement of proposed NKF-K/DOQI Bone Metabolism and Disease targets: Treatment with cinacalcet HCl in dialysis patients with uncontrolled secondary hyperparathyroidism (HPT). Kidney Int 2005 67 : 760 71.
11. Yajima A, Inaba M, Ogawa Y et al. Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism. Nephrol Dial Transplant 2007 22 : 1645 57.
12. Moe S, Drûeke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006 69 : 1945 53.
13. Yajima A, Ogawa Y, Takahashi HE et al. Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism. Am J Kidney Dis 2003 42 : 729 38.
14. Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomorphometry: Standardization of nomenclature, symbols and units. J Bone Miner Res 1987 2 : 595 610.
15. Yajima A, Inaba M, Tominaga Y, Ito A. Bone formation by minimodeling is more active than remodeling after parathyroidectomy. Kidney Int 2008 74 : 775 81.
16. Torres A, Lorenzo V, Hernández D et al. Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 1995 47 : 1434 42.
17. Goodman WG, Ramirez JA, Belin TR et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 1994 46 : 1160 6.
18. Malluche HH, Monier-Faugere MC. Renal bone disease 1990. An unmet challenge for the nephrologist. Kidney Int 1990 38 : 193 211.
19. Akiba T, Akizawa T, Tsukamoto Y et al. Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial 2008 12 : 117 25.
20. Block GA, Zeig S, Suguhara J et al. Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial Transplant 2008 23 : 2311 18.
21. Chertow GM, Blumenthal S, Turner S et al. Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium × phosphate. Clin J Am Soc Nephrol 2006 1 : 305 12.
22. Fereira A, Frazao JM, Monier-Faugere MC et al. (Sevelemer Study Group). Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol 2008 19 : 405 12.
23. Freemont T, Malluche HH. Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate. Clin Nephrol 2005 63 : 138 45.
24. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000 11 : 1093 9.
25. Yajima A, Inaba M, Tominaga Y et al. Impact of parathyroidectomy on multinucleated and mononucleated osteoclasts on the cancellous, endocortical and intracortical surfaces in patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2007 22 (Suppl. 6 vi.356.